(Q40627104)

22 September 2017

title

Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors (English)

1 reference

22 September 2017

Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors (English)

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

20 March 2024

main subject

proto-oncogene protein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

20 March 2024

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

20 March 2024

author name string

Concha Sanchez-Martinez

1

1 reference

22 September 2017

Chuan Shih

2

1 reference

22 September 2017

Guoxin Zhu

4

1 reference

22 September 2017

Michael Paal

5

1 reference

22 September 2017

Carmen Somoza

6

1 reference

22 September 2017

Tiechao Li

7

1 reference

22 September 2017

Zhou Xun

10

1 reference

22 September 2017

Eileen Considine

17

1 reference

22 September 2017

Jill Wagner

22

1 reference

22 September 2017

Margaret M. Faul

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Christine A. Kumrich

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Leonard L. Winneroski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Harold B. Brooks

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Bharvin K. R. Patel

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Richard M. Schultz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Tammy B. DeHahn

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Charles D. Spencer

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Scott A. Watkins

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Jack A. Dempsey

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Catherine A. Ogg

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Robert M. Campbell

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

Bryan A. Anderson

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14552791

20 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

3 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14552791

full work available at URL

20 March 2024

https://api.elsevier.com/content/article/PII:S0960894X03007911?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

https://api.elsevier.com/content/article/PII:S0960894X03007911?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

Bioorganic & Medicinal Chemistry Letters

20 March 2024

published in

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

21

1 reference

22 September 2017

page(s)

3835-3839

1 reference

Cyclins and cyclin-dependent kinases: take your partners

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

1 reference

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Chemical inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Structure-activity relationship studies of flavopiridol analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

3D-QSAR CoMFA on cyclin-dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Beta-carbolines as specific inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Identification of selective inhibitors of cyclin dependent kinase 4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Studies on cyclin-dependent kinase inhibitors: indolo-[2,3- a ]pyrrolo[3,4- c ]carbazoles versus bis-indolylmaleimides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

A New, Efficient Method for the Synthesis of Bisindolylmaleimides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900791-1

7 January 2021

5

27

351

Palmero

1996

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00791-1

20 March 2024

Identifiers

1 reference

22 September 2017

1 reference